Redefining Excellence in Bioabsorbable Medical Devices

A once-in-a-generation innovation, set to revolutionise the future of bioabsorbable medical devices.

Groundbreaking Research

After 15 years of groundbreaking research, Professor Andrew Dove – a world leader in bioabsorbable polymer chemistry – has developed 4Degra®, a patented, game-changing implantable medical polymer.

4D is focused on two critical areas of innovation designed to improve surgical outcomes and enhance patient quality of life worldwide.

Biomaterials

4D’s patented polymer resin platform, 4Degra®, delivers an improved biodegradation profile, enhanced biocompatibility and unique 3D printing capability, unlocking the full potential of biodegradable medical devices in a global market worth over $1bn.

Learn more

Medical Devices

4D is utilising the benefits of 4Degra® to design and develop novel bioabsorbable medical devices that can be manufactured through 3D printing to a higher resolution at any dimensional scale. The goal is to improve surgical outcomes and leverage a technological breakthrough in a $6bn global marketplace.

Learn more

Ongoing FDA Application

4D is currently taking its first product, a bioabsorbable interference screw featuring 4Degra® polymer resin through the U.S. FDA 510(k) regulatory pathway. This product will act as a critical stepping stone to the future clearance of more complex medical devices in 4D’s development pipeline.

Investor & Partnership
Opportunities

4D has a number of significant private investors backing material science and medical device development. The company is also actively pursuing partnerships with novel medical device and sales channel organisations.